Pain management: Neuromodulation company Nevro closes $58 million round

July 19, 2011 by MassDevice staff

Nevro Corp. closes $58 million financing round to fund U.S. pivotal trial of spinal cord stimulation system for pain management.

Nevro Corp., an early stage company that makes a spinal cord stimulator for chronic pain, has raised $58 million to continue development of its flagship product and prepare for a possible U.S. launch.

The Menlo Park, Calif.-based company said the funding round was led by Johnson & Johnson Development Corp. (NYSE: JNJ), along with existing investors Aberdare Ventures, Accuitive Medical Ventures, Bay City Capital, Mayo Clinic, MPM Capital and Three Arch Partners.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.